Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • nsl
    Member
    • Jan 2011
    • 28

    #1

    1 lane per treatment vs. multiplexing for rnaseq

    Hi all,

    I ran a pilot for an experiment which had 3 treatments using 1 lane per treatment . We have funds to pay for 3 more full lanes of sequencing. My question is

    Should I run each treatment as I did for the pilot ( using 1 lane per treatment)

    or

    Should I multiplex and run all 3 treatments on each of the sequencing lanes?

    Would I roughly get the same coverage as running a single treatment per lane?

    Any insight would be greatly appreciated.

    nsl
  • lukas1848
    Member
    • Jun 2011
    • 54

    #2
    you should multiplex to prevent any technical bias from the lane.

    Have a look at this very nice paper on that.

    Auer, P. L., & Doerge, R. W. (2010). Statistical design and analysis of RNA sequencing data. Genetics, 185(2), 405–416. doi:10.1534/genetics.110.114983

    Comment

    • nsl
      Member
      • Jan 2011
      • 28

      #3
      thank you

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...